Atara Biotherapeutics Inc logo

Atara Biotherapeutics Inc

3
NAS:ATRA (USA)  
$ 0.69 -0.006 (-0.86%) 11:08 PM EST
At Loss
Market Cap:
$ 70.73M
Enterprise V:
$ 30.74M
Volume:
1.19M
Avg Vol (2M):
3.48M
Also Trade In:
Volume:
1.19M
At Loss
Avg Vol (2M):
3.48M

Business Description

Description
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
Name Current Vs Industry Vs History
Cash-To-Debt 1.66
Equity-to-Asset -0.27
Debt-to-Equity -1.22
Debt-to-EBITDA -0.19
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -18.7
Distress
Grey
Safe
Beneish M-Score -1.22
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 54.98
9-Day RSI 50.45
14-Day RSI 48.93
6-1 Month Momentum % -50.29
12-1 Month Momentum % -73.41

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.5
Quick Ratio 1.42
Cash Ratio 1.29
Days Inventory 340.68
Days Sales Outstanding 667.59
Days Payable 431.98

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -19.1
Shareholder Yield % -74.5
Name Current Vs Industry Vs History
Gross Margin % -26.07
Operating Margin % -6419.71
Net Margin % -6390.31
FCF Margin % -4418.03
ROE % -432.78
ROA % -97.92
ROIC % -248.4
ROC (Joel Greenblatt) % -477.23
ROCE % -152.61

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 16.15
EV-to-EBIT -0.09
EV-to-EBITDA -0.09
EV-to-Revenue 6.77
EV-to-Forward-Revenue 2.93
EV-to-FCF -0.15
Earnings Yield (Greenblatt) % -1111.11
FCF Yield % -283.68

Financials (Next Earnings Date:2024-05-08 Est.)

ATRA's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ATRA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Atara Biotherapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 4.542
EPS (TTM) ($) -2.78
Beta -0.56
Volatility % 93.99
14-Day RSI 48.93
14-Day ATR ($) 0.081485
20-Day SMA ($) 0.690075
12-1 Month Momentum % -73.41
52-Week Range ($) 0.1986 - 3.08
Shares Outstanding (Mil) 101.92

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Atara Biotherapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Atara Biotherapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Atara Biotherapeutics Inc Frequently Asked Questions

What is Atara Biotherapeutics Inc(ATRA)'s stock price today?
The current price of ATRA is $0.69. The 52 week high of ATRA is $3.08 and 52 week low is $0.20.
When is next earnings date of Atara Biotherapeutics Inc(ATRA)?
The next earnings date of Atara Biotherapeutics Inc(ATRA) is 2024-05-08 Est..
Does Atara Biotherapeutics Inc(ATRA) pay dividends? If so, how much?
Atara Biotherapeutics Inc(ATRA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1